American Bio Medica (ABMC) Stock Price, News & Analysis

Company Overview

American Bio Medica Corporation is a biopharmaceutical company headquartered in West Palm Beach, Florida, focused on the development and commercialization of therapeutics for neurodegenerative diseases. The company’s research pipeline comprises small-molecule and biologic candidates designed to address cognitive impairment, vascular dementia and Parkinson’s disease by targeting disease-specific pathways. Through preclinical models and early-phase clinical trials, ABMC seeks to advance its lead compounds toward proof-of-concept and regulatory milestones.

In addition to its proprietary drug development programs, ABMC operates a wholly owned subsidiary, Food and Drug Sciences, Inc., which provides contract research services. This subsidiary performs GLP-compliant toxicology, pharmacology and regulatory consulting for pharmaceutical, biotechnology and medical device clients. By offering comprehensive safety assessments and guidance on regulatory submissions, Food and Drug Sciences generates supplemental revenue while reinforcing ABMC’s in-house development expertise.

Serving customers primarily across the United States, American Bio Medica leverages its integrated research and CRO capabilities to move product candidates from discovery through early clinical evaluation. The company’s leadership team brings experience in clinical development, toxicology and regulatory affairs, positioning ABMC to pursue strategic partnerships and licensing opportunities that can drive growth and facilitate the transition of its pipeline assets toward commercialization.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ABMC Stock Analysis - Frequently Asked Questions

How were American Bio Medica's earnings last quarter?

American Bio Medica Corp. (OTCMKTS:ABMC) issued its quarterly earnings results on Monday, May, 14th. The company reported ($0.01) EPS for the quarter. The company earned $1.04 million during the quarter.

How do I buy shares of American Bio Medica?

Shares of ABMC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of American Bio Medica own?

Based on aggregate information from My MarketBeat watchlists, some other companies that American Bio Medica investors own include FuelCell Energy (FCEL), OPKO Health (OPK), Canadian Western Bank (CWB), Canopy Growth (CGC), Newmont (NEM), Cortex Pharmaceuticals (RSPI) and V Group (VGID).

Company Calendar

• Last Earnings: 5/14/2018
• Today: 10/09/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:ABMC
• CIK: 896747
• Web: www.abmc.com
• Phone: (518) 758-8158
• Fax: 518-758-8171
• Employees: 30
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $910 thousand
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A